Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
Dickerson
L M
LM
Medical University of South Carolina, Charleston, SC, USA. macfarll@musc.edu
Carek
P J
PJ
D000319:Adrenergic beta-Antagonists / Q000191:economics / Q000627:therapeutic use*; D000368:Aged; D001262:Atenolol / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000191:economics / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D011433:Propranolol / Q000191:economics / Q000627:therapeutic use*; D012107:Research Design / Q000592:standards; D016019:Survival Analysis; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D011433:Propranolol; D008790:Metoprolol